Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,598,338 papers from all fields of science
Search
Sign In
Create Free Account
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Known as:
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [Chemical/Ingredient]
, Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate
, Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination
Expand
A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Broader (1)
Anti-HIV Agents
In Blood
agonists
antagonists & inhibitors
aspects of radiation effects
Expand
Narrower (2)
Quad Pill
Stribild
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Uso de elvitegravir/cobicistat durante el embarazo: riesgo de fracaso terapéutico y transmisión de la infección VIH de madre a hijo
A. E. D. M. Y. P. Sanitarios
2019
Corpus ID: 203814322
Elvitegravir es un antiretroviral inhibidor de la integrasa(1) indicado, en combinación con otros antirretrovirales, para el…
Expand
2016
2016
Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
J. Llibre
,
F. Raffi
,
+6 authors
F. Rogatto
PLoS ONE
2016
Corpus ID: 8136823
[This corrects the article DOI: 10.1371/journal.pone.0155406.].
2016
2016
Jounce checkpoint lures Celgene
Nature Biotechnology
2016
Corpus ID: 205271229
2015
2015
Changes in Cognitive Function over 96 Weeks after Initiating Darunavir/Ritonavir with Either Raltegravir or Tenofovir-Emtricitabine: NEAT 001 / ANRS 143 Randomised Controlled Study
A. Winston
,
W. Stöhr
,
+11 authors
L. Richert
2015
Corpus ID: 74834418
Review
2014
Review
2014
Study of Tourism Industry in Urban Planning with Priority of Medical Tourism in Iran
R. Lahmian
2014
Corpus ID: 56023303
Urban planning is important in any industry, especially the tourism industry. Health tourism is a fast growing industry and…
Expand
2013
2013
Boosting HIV treatment options: good news, new challenges.
P. Cahn
,
O. Sued
Journal of Infectious Diseases
2013
Corpus ID: 14457429
Keywords. pharmacoenhancer; cobicistat; boosted PIs.For >15 years, ritonavir (RTV) has beenthe only pharmacokinetic enhancer (ie…
Expand
2013
2013
CHAPTER 14:Clinical Benefits of Single‐tablet Regimens
D. Porter
,
Bill Guyer
2013
Corpus ID: 75530993
Since the advent of highly active antiretroviral therapy, considerable progress has been made in the treatment of HIV infection…
Expand
Review
2013
Review
2013
Emtricitabine-tenofovir ( Truvada ) Abbreviated Review for Pre-Exposure Prophylaxis of HIV May 2013
Emtricitabine-tenofovir Truvada
2013
Corpus ID: 38276324
In July 2012, the FDA approved the use emtricitabine-tenofovir (FTC-TDF) as pre-exposure prophylaxis (PrEP) for the prevention…
Expand
2012
2012
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) compared to ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF in treatment naive HIV-1 infected subjects
E. Dejesus
,
J. Rockstroh
,
+7 authors
A. Cheng
2012
Corpus ID: 74502038
2012
2012
The efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir DF ('Quad') compared to efavirenz/emtricitabine/tenofovir DF in treatment naive HIV-1 infected subjects: primary results of…
P. Sax
,
E. Dejesus
,
+8 authors
B. Kearney
2012
Corpus ID: 74549735